Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.

Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings. Abstract Text:

    wei-zhong zhouWei-Zhong Zhou,hye-won kooHye-Won Koo,xuan-yi wangXuan-Yi Wang,jun zhangJun Zhang,jin-kyung parkJin-Kyung Park,fengcai zhuFengcai Zhu,jacqueline deenJacqueline Deen,camilo j acostaCamilo J Acosta,yan chenYan Chen,hua wangHua Wang,claudia m galindoClaudia M Galindo,leon ochiaiLeon Ochiai,taesung parkTaesung Park,lorenz von seidleinLorenz von Seidlein,zhi-yi xuZhi-Yi Xu,john d clemensJohn D Clemens,wei-zhong zhouWei-Zhong Zhou,hye-won kooHye-Won Koo,xuan-yi wangXuan-Yi Wang,jun zhangJun Zhang,jin-kyung parkJin-Kyung Park,fengcai zhuFengcai Zhu,jacqueline deenJacqueline Deen,camilo j acostaCamilo J Acosta,yan chenYan Chen,hua wangHua Wang,claudia m galindoClaudia M Galindo,leon ochiaiLeon Ochiai,taesung parkTaesung Park,lorenz von seidleinLorenz von Seidlein,zhi-yi xuZhi-Yi Xu,john d clemensJohn D Clemens,

    OBJECTIVE: To evaluate the safety and immunogenicity of revaccination with locally-produced Vi polysaccharide vaccine 3 years after the first dose in Chinese children aged 9 to 14 years. METHODS: A randomized, placebo-controlled trial was conducted in Suzhou, Jiangsu, China. Six hundred and sixty-seven eligible children who had previously received a primary dose of Vi vaccine were randomly assigned to receive 1 dose of 30 mug Vi vaccine or placebo. In addition, 331 eligible children received 1 dose of Vi polysaccharide vaccine as a primary vaccination. Adverse events were followed for 28 days after vaccination. Serum samples were collected from a subgroup of participants on day 0 and day 28, and Vi antibodies were analyzed using a passive hemagglutination method. RESULTS: Revaccination was found to be safe and immunogenic. No severe adverse events were observed. A significant increase in antibody titers after vaccination was observed among children who had and had not been previously vaccinated. Twenty-eight days after injection, the seropositive rate was 79% in both revaccination and primary injection groups; the geometric mean antibody titer was 1:40 in the primary injection group and 1:29 in the revaccination group (P = 0.24). Although the difference of attained geometric mean titers in follow-up sera was not significantly different in these 2 groups, the fold-rise of these titers from baseline was significantly higher in the primary injection group than in the revaccination group (7.7 versus 3.1, P < 0.001). CONCLUSION: We found that revaccination using the locally produced Vi polysaccharide vaccine among Chinese school-aged children was safe and increased antibody titers. Revaccination can be used to extend the duration of protection provided by Vi polysaccharide vaccine.

    Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings. Publishing Authors By Initials

    wz zhouWZ Zhou,hw kooHW Koo,xy wangXY Wang,j zhangJ Zhang,jk parkJK Park,f zhuF Zhu,j deenJ Deen,cj acostaCJ Acosta,y chenY Chen,h wangH Wang,cm galindoCM Galindo,l ochiaiL Ochiai,t parkT Park,l von seidleinL von Seidlein,zy xuZY Xu,jd clemensJD Clemens,wz zhouWZ Zhou,hw kooHW Koo,xy wangXY Wang,j zhangJ Zhang,jk parkJK Park,f zhuF Zhu,j deenJ Deen,cj acostaCJ Acosta,y chenY Chen,h wangH Wang,cm galindoCM Galindo,l ochiaiL Ochiai,t parkT Park,l von seidleinL von Seidlein,zy xuZY Xu,jd clemensJD Clemens,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The Pediatric infectious disease journal

    VOLUME: 26

    Page Numbers: 1001-5

    Journal Abbreviation: Pediatr. Infect. Dis. J.

    ISSN: 0891-3668

    DAY: 6

    MONTH: Nov

    YEAR: 2007

    Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8701858

    Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.

    AFFILIATION: Jiangsu Provincial Center for Disease Prevention and Control, Nanjing, China.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Pediatr Infect Dis J

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News